Nicolet Advisory Services, LLC Alaunos Therapeutics, Inc. Transaction History

Nicolet Advisory Services, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 03, 2021	SELL	$2.82 - $5.6 $2,975 - $5,908	-1,055 Reduced 4.68%	21,500 $77,000
Q3 2020 Oct 27, 2020	BUY	$2.39 - $3.43 $53,906 - $77,363	22,555 New	22,555 $57,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Nicolet Advisory Services, LLC with notifications on news.